abbvie glp-1 joins the weight loss race Bariatric Fusion GLP abbvie glp-1 receptor agonists weight

For comparison, once-weekly injections of Lillys Zepbound have helped participants shed 15% to 21% of their starting weight after 72 weeks in clinical trials

Subsequent longitudinal studies involving a larger and more diverse global study population will enhance our understanding of the enduring corrective effects of retatrutide, particularly in relation to cardiovascular health outcomes

When to Contact Your Doctor or Seek Emergency Care Most injection site reactions are mild and resolve on their own, but knowing when to seek medical attention is essential to avoid complications

That said, here are some groups of people who are typically not candidates for semaglutide or advised to use it with caution: History of Pancreatitis Individuals with a history of pancreatitis, which is inflammation of the pancreas, should avoid semaglutide due to the potential risk of exacerbating the condition

That study used 3.5 grams of resistant potato starch per day